News archive
BNP Paribas Group: Results as at 31st March 2022
The Board of Directors of BNP Paribas met on 2 May 2022. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2022.
BNP Paribas Group: Results as at 31 December 2021
The Board of Directors of BNP Paribas met on 7 February 2022, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter 2021 and endorsed the 2021 financial statements.
BNP Paribas Group: Results as at 30 September 2021
The Board of Directors of BNP Paribas met on 28 October 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the third quarter 2021.
BNP Paribas launches a share buyback program of 900 million euros
On the strength of its confirmed growth potential and solid balance sheet and performances, BNP Paribas announces today the launch of a share buyback program of BNP Paribas S.A. ordinary shares for a maximum total amount of €900 million. BNP…
BNP Paribas Group: Results as at 30 June 2021
The Board of Directors of BNP Paribas met on 29 July 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the second quarter 2021.
BNP Paribas receives approvals and completes the acquisition of Exane
BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for
BNP Paribas Group: Results as at 31 March 2021
The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.
BNP Paribas is looking to acquire up to 100% of Exane*
After a successful 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane*, raising its stake from the 50% currently held.
BNP Paribas Group: Results as at 31 December 2020
The Board of Directors of BNP Paribas met on 4 February 2021, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter and endorsed the 2020 financial statements.
News archive
BNP Paribas Group: Results as at 31st March 2022
The Board of Directors of BNP Paribas met on 2 May 2022. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2022.
BNP Paribas Group: Results as at 31 December 2021
The Board of Directors of BNP Paribas met on 7 February 2022, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter 2021 and endorsed the 2021 financial statements.
BNP Paribas Group: Results as at 30 September 2021
The Board of Directors of BNP Paribas met on 28 October 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the third quarter 2021.
BNP Paribas launches a share buyback program of 900 million euros
On the strength of its confirmed growth potential and solid balance sheet and performances, BNP Paribas announces today the launch of a share buyback program of BNP Paribas S.A. ordinary shares for a maximum total amount of €900 million. BNP…
BNP Paribas Group: Results as at 30 June 2021
The Board of Directors of BNP Paribas met on 29 July 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the second quarter 2021.
BNP Paribas receives approvals and completes the acquisition of Exane
BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for
BNP Paribas Group: Results as at 31 March 2021
The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.
BNP Paribas is looking to acquire up to 100% of Exane*
After a successful 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane*, raising its stake from the 50% currently held.
BNP Paribas Group: Results as at 31 December 2020
The Board of Directors of BNP Paribas met on 4 February 2021, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter and endorsed the 2020 financial statements.
